Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia

  • End date
    Dec 30, 2022
  • participants needed
  • sponsor
    Pakistan Institute of Living and Learning
Updated on 9 May 2022


This a randomized double-blind placebo controlled trial which aims to determine the beneficial effects of minocycline augmentation to clozapine in partial responders to Treatment Resistant Schizophrenia (TRS).


The primary objective is to determine if the addition of minocycline to Clozapine, Treatment as Usual (TAU) Improves negative symptoms and/or positive symptoms.

The secondary objectives are to determine:

  • Effects on cognitive functioning.
  • Effects on social functioning and quality of life.
  • Safety and tolerability.
  • Possible additive effects of Minocycline added to TAU
  • The effect on inflammatory biomarkers associated with schizophrenia. Both pro and anti-inflammatory cytokines will be drawn at baseline and endpoint. We will test to see if minocycline is associated with improvements in abnormal cytokines as compared to placebo.

The study will be a randomized double-blind placebo controlled trial of minocycline added to clozapine (Treatment as Usual) in TRS. There will be two treatment arms: one arm receiving TAU with minocycline and the other TAU with placebo for a period of twelve weeks.

Condition Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
Treatment Minocycline
Clinical Study IdentifierNCT02533232
SponsorPakistan Institute of Living and Learning
Last Modified on9 May 2022


Yes No Not Sure

Inclusion Criteria

Male and female patients aged between 18-65 years, IQ >70 (to complete assessments) identified by treating psychiatrist
Confirmation of schizophrenia by using The MINI psychiatric interview (at baseline only)
Assessed as competent to provide informed consent by treating psychiatrist
Antipsychotic medication has remained stable 4 weeks prior to baseline . Assessed as a partial responder to clozapine: patients prescribed clozapine at a stable therapeutic dose for a minimum of 3 months with total Positive and Negative Syndrome Schizophrenia (PANSS) score >70

Exclusion Criteria

Prior history of intolerance or serious side effects (hepatotoxicity, photosensitivity, blood dyscrasias) to any of the Tetracyclines
Concomitant Penicillin therapy or concomitant anticoagulant therapy
Active substance abuse (except nicotine or caffeine) or dependence within the last three months according to ICD 10 criteria
Treatment with Warfarin or Lamotrigine
Current or previous treatment with minocycline or other tetracycline antibiotics in the preceding three months before study entry
Relevant current or past hematologic, hepatic, renal, neurological or other medical disorder that in the opinion of the principal investigator may interfere with the study
Pregnant or breast-feeding females
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note